Filing Details
- Accession Number:
- 0001181431-13-007059
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-06 10:19:37
- Reporting Period:
- 2013-02-04
- Filing Date:
- 2013-02-06
- Accepted Time:
- 2013-02-06 10:19:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
722104 | Savient Pharmaceuticals Inc | SVNT | Medicinal Chemicals & Botanical Products (2833) | 133033811 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1527197 | Kenneth Bahrt | 400 Crossing Blvd. 3Rd Floor Bridgewater NJ 08807 | Svp, Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock $.01 Par Value Per Share | Disposition | 2013-02-04 | 7,300 | $1.01 | 193,450 | No | 4 | S | Direct | |
Common Stock $.01 Par Value Per Share | Disposition | 2013-02-04 | 21,700 | $1.04 | 171,750 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- These shares were sold automatically pursuant to a binding contract under Rule 10b5-1 of the Securities Exchange Act of 1934 to cover tax withholding obligations in connection with the vesting of restricted stock granted on February 1, 2012.